Oral Probiotic Supplementation and Group B Streptococcus Rectovaginal Colonization in Pregnant Women: a Randomized Double-blind Placebo-controlled Trial.
The investigators wish to determine if oral probiotic supplementation during the second half of pregnancy decreases maternal GBS recto-vaginal colonization at 35-37 weeks' gestational age, thereby decreasing need for maternal antibiotic administration at time of labor. The importance of this study is that it may offer a safer alternative to antibiotic treatment of group B Streptococcus (GBS) colonized pregnant women.
Stanford is now accepting new patients for this trial.
- dietary supplement : Probiotic dietary supplement
- dietary supplement : Placebo
Phase: Phase 1/Phase 2
Ages Eligible For Study:
1. Pregnant women between 20-28 weeks gestation. 2. 18 years of age or older. 3. Singleton gestation.